Article
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Dec 2021
Pepe Giovanna, Sfogliarini Chiara, Rizzello Loris, Battaglia Giuseppe, Pinna Christian, Rovati Gianenrico, Ciana Paolo, Brunialti Electra, Mornata Federica, Maggi Adriana, Locati Massimo, Vegeto Elisabetta
Abstract excerpt
Sex differences in immune-mediated diseases are linked to the activity of estrogens on innate immunity cells, including macrophages. Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) used in estrogen receptor-alpha (ERα)-dependent breast cancers and off-target indications such as infections, although the immune activity of TAM and its active metabolite, 4-OH tamoxifen (4HT), is poorly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
